Price of second-line antiretroviral therapy reduced.
D044966:Anti-Retroviral Agents / Q000191:economics* / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics; D006297:Health Services Accessibility; D006801:Humans; D014944:World Health Organization
D044966:Anti-Retroviral Agents